Advertisement

Low-dose continuous renal replacement therapy for acute kidney injury

Abstract

Background: Continuous renal replacement therapy (CRRT) is used increasingly to treat acute kidney injury (AKI), which is a common condition in the intensive care unit (ICU). However, the optimal CRRT dose for the treatment of AKI is still a matter of controversy. This study was conducted to ascertain the minimal dose of CRRT that can be effective on AKI patient outcomes. Methods: This was a retrospective observational study in two ICUs of academic medical centers in Japan. Patients aged 15 years or older admitted to the ICUs from January 2007 to July 2010 and treated with CRRT for AKI during their ICU stay were included. Data were retrospectively collected from patient records. Patients were categorized by doses that were above (higher-dose group) or below (lower-dose group) the median. Major outcome measures were hospital mortality, ICU mortality, and renal recovery at hospital discharge. Results: 131 AKI patients were treated with continuous veno-venous hemodiafiltration (CVVHDF) during the study period. The median dose of CVVHDF was 16 ml/kg per hr (IQR = 14 to 20). Hospital mortality was 44%, which was significantly lower than the predicted mortality (56%, p>0.01). Patients who received lower-dose CRRT tend to have lower mortality rates (36% vs. higher-dose 53%; p = 0.055). Conclusions: We found that low-dose CRRT did not increase mortality in critically ill patients with AKI. We also found that AKI patients treated with lower-dose CRRT non-significantly but numerically lower hospital mortality compared to higher-dose CRRT.

Int J Artif Organs 2012; 35(7): 525 - 530

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.5301/ijao.5000110

Authors

Tomoko Fujii, Yoshitomo Namba, Shigeki Fujitani, Jun Sasaki, Kentarou Narihara, Yugo Shibagaki, Shigehiko Uchino, Yasuhiko Taira

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Fujii, Tomoko [PubMed] [Google Scholar]
    Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki - Japan
  • Namba, Yoshitomo [PubMed] [Google Scholar]
    Department of Emergency and Critical Care Medicine, Showa University Fujigaoka Hospital, Yokohama - Japan
  • Fujitani, Shigeki [PubMed] [Google Scholar]
    Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki - Japan
  • Sasaki, Jun [PubMed] [Google Scholar]
    Department of Emergency and Critical Care Medicine, Showa University Fujigaoka Hospital, Yokohama - Japan
  • Narihara, Kentarou [PubMed] [Google Scholar]
    Department of Emergency and Critical Care Medicine, Showa University Fujigaoka Hospital, Yokohama - Japan
  • Shibagaki, Yugo [PubMed] [Google Scholar]
    Division of Nephrology and Hypertension, St. Marianna University School of Medicine, Kawasaki - Japan
  • Uchino, Shigehiko [PubMed] [Google Scholar]
    Intensive Care Unit, Department of Anesthesiology, The Jikei University School of Medicine, Tokyo - Japan
  • Taira, Yasuhiko [PubMed] [Google Scholar]
    Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki - Japan

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.